Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Cellular Biomedicine Group, Inc. | Financial_Report.xls |
| EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex311.htm |
| EX-32.2 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex322.htm |
| EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex312.htm |
| EX-32.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex321.htm |
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | ebig_fs.htm |
| EX-4.6 - INCENTIVE STOCK PLAN - Cellular Biomedicine Group, Inc. | ebig_ex46.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to incorporation by reference in each of the Registration Statements of Cellular Biomedicine Group, Inc. (formerly, EastBridge Investment Group Corporation) (the “Company”) on Form S-8 (No. 333-179974), of Form S-8 (No. 333-158583), on Form S-8 (No. 333-153129), on Form S-8 (No. 333-143878), of our report, dated March 29, 2013, relating to the consolidated financial statements of the Company for the fiscal year ended December 31, 2012.
Tarvaran Askelson & Company, LLP
Laguna Niguel, California
March 29, 2013